Pay in 4 interest-free payments of $9.00 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
In relevant biological assays
The invasion and mobile abilities of OS cells are also markedly suppressed by apcin treatment
and MDA-MB436 ER negative breast cancer cells
After 24 h
425613-09-8
Bisindolylmaleimide I (GF109203X) - CAS# 133052-90-1 0012 In relevant biological assaysBisindolylmaleimide I (GF109203X), a potent and highly selective PCK inhibitor., CAS No. 133052 90 1, is a potent and highly selective PCK inhibitor. bisindolylmaleimide I(GF 109203X )inhibits PKC isozymes alpha, beta 1, beta 2, gamma, delta and epsilon in vitro . GF 109203X inhibited GSK 3 in vitro, when assayed either in cell lysates (IC(50) 360 nM or in GSK 3beta immunoprecipitates (IC(50) 170 nM derived from rat epididymal adipocytes. Pretreatment
US$ 99.00
US$ 20.00
US$ 75.00
US$ 48.00
US$ 53.00
US$ 64.00